Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹12 Cr
P/E Ratio
148.44
P/B Ratio
1.24
Industry P/E
36.27
Debt to Equity
0.57
ROE
9.07 %
ROCE
11.14 %
Div. Yield
0 %
Book Value
18.39
EPS
0.15
CFO
₹7.35 Cr
EBITDA
₹10.74 Cr
Net Profit
₹3.11 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Beryl Drugs
| -36.85 | -2.10 | -34.75 | -34.21 | 30.30 | 38.16 | -5.76 |
|
BSE Healthcare
| -7.27 | -1.01 | -0.76 | 19.87 | 19.29 | 22.12 | 9.77 |
|
BSE Small Cap
| -12.38 | 0.32 | -4.19 | 2.45 | 17.96 | 35.18 | 15.87 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Beryl Drugs
| 60.31 | 70.08 | 7.26 | 45.60 | 60.94 | -48.80 | -2.23 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 735.15 | 6,661.19 | 26.72 | 13.8 | |
| 1,069.80 | 8,742.78 | 72.03 | 12.96 | |
| 452.55 | 10,967.83 | 22.89 | 14.4 | |
| 884.20 | 5,068.41 | 39.78 | 14.76 |
No Review & Analysis are available.
Beryl Drugs Limited manufactures and markets branded and generic pharmaceutical formulations in India. The company offers I.V. fluids and small volume injectables, as well as veterinary products. It also provides research and development, and... contract manufacturing services. Beryl Drugs Limited was founded in 1993 and is based in Indore, India. Read more
Incorporated
1993
Chairman
Sudhir Sethi
Managing Director
Sanjay Sethi
Headquarters
Indore, Madhya Pradesh
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The total asset value of Beryl Drugs Ltd stood at ₹ 17 Cr as on 31-Dec-24
The share price of Beryl Drugs Ltd is ₹22.83 (BSE) as of 25-Apr-2025 IST. Beryl Drugs Ltd has given a return of 30.3% in the last 3 years.
Beryl Drugs Ltd has a market capitalisation of ₹ 12 Cr as on 25-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Beryl Drugs Ltd is 1.24 times as on 25-Apr-2025, a 66% discount to its peers’ median range of 3.63 times.
The P/E ratio of Beryl Drugs Ltd is 148.44 times as on 25-Apr-2025, a 309% premium to its peers’ median range of 36.27 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Beryl Drugs Ltd and enter the required number of quantities and click on buy to purchase the shares of Beryl Drugs Ltd.
Beryl Drugs Limited manufactures and markets branded and generic pharmaceutical formulations in India. The company offers I.V. fluids and small volume injectables, as well as veterinary products. It also provides research and development, and contract manufacturing services. Beryl Drugs Limited was founded in 1993 and is based in Indore, India.
The prominent promoters of Beryl Drugs Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
SANJAY SETHI |
10.88%
|
|
SUDHIR SETHI |
8.65%
|
|
SANGITA SETHI |
3.78%
|
|
SONIYA SETHI |
3.07%
|
The chairman of the company is Sudhir Sethi, and the managing director is Sanjay Sethi.
There is no promoter pledging in Beryl Drugs Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
10,968
|
|
|
8,743
|
|
|
6,661
|
|
|
5,068
|
| Beryl Drugs Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
0.87
|
|
Operating margin(%)
|
4.5
|
|
Net Margin(%)
|
0.38
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Beryl Drugs Ltd was ₹0 Cr.
₹-0.14
(
